Tips For Staying Consistent Through Early Challenges Consistency is key to achieving your weight loss goals with GLP-1 therapy
If you are unable to keep fluids down, contact your study team, GP, or NHS 111 promptly
The entire conversion rests on three small equations
[1] Baseline Cardiovascular Profile The SELECT study is a large cardiovascular outcomes trial designed to assess whether semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), can reduce cardiovascular events in people who are overweight or obese but do not have diabetes
These tips will help you minimize stomach issues safely
Risks & limits: Possible GI side effects , contraindications, medication interactions, and insurance coverage gaps for off-label use